Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health ADHD

Stimulant medication improves working memory of children with ADHD, study finds

by Vladimir Hedrih
March 3, 2025
in ADHD, Psychopharmacology
[Adobe Stock]

[Adobe Stock]

Share on TwitterShare on Facebook
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights.

A study examining how working memory in children with ADHD varies with the use of stimulant medication found that these medications improve working memory. Both phonological and visuospatial working memory were better when children took medication and were more physically active during memory tasks. The effects of the medications on visuospatial memory were strongest in children who were most physically active during the tasks. The paper was published in Research on Child and Adolescent Psychopathology.

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects attention, impulse control, and activity levels. It is commonly diagnosed in childhood (most often at the start of school) but can persist into adulthood. Symptoms include difficulty focusing, excessive movement, impulsive decision-making, and trouble organizing tasks.

Treatment for ADHD includes psychotherapy, lifestyle adjustments, and medication. Stimulant medications are the most common treatment for ADHD. These medications can help improve focus and impulse control while reducing hyperactivity. They work by increasing the levels of the neurotransmitters dopamine and norepinephrine, thereby enhancing attention and self-regulation. Common stimulants include methylphenidate (e.g., Ritalin, Concerta) and amphetamines (e.g., Adderall, Vyvanse).

Study author Emily Wiegers and her colleagues sought to examine the relationship between stimulant medication usage, body movements, and working memory performance in children with ADHD. They were particularly interested in the interaction between stimulant medication and children’s physical activity (i.e., how much they move) and its potential effects on working memory performance.

The researchers conducted a study in which they examined the working memory and physical activity levels of children with ADHD both when they were on stimulant medications and when they were not. They analyzed a publicly available dataset from the Summer Treatment Program at Florida International University—an 8-week behavioral intervention delivered in a summer camp setting for children between 6 and 12 years of age with ADHD. Data came from 43 children who participated in the camp, with an average age of 10 years, 81% of whom were boys.

During the first two weeks of the summer camp, the researchers determined the optimal medication dose for each participating child. Next, the children were randomly assigned to either receive the medication for the following three weeks or a placebo (a similarly looking capsule with no active ingredients). After three weeks on this regimen, the groups switched for the next three weeks—the group that had been taking the placebo started taking the stimulant medication, and vice versa.

During these six weeks, the children completed an extensive battery of neurocognitive tasks on four occasions. These tasks were used to assess two types of working memory: phonological memory and visuospatial memory. Phonological memory is the ability to temporarily store and manipulate verbal information, while visuospatial memory involves holding and processing visual and spatial details. While completing the cognitive tasks, participants wore actigraphy devices in the form of watches on their wrists and ankles to track their physical movements.

Results showed that participants performed significantly better on phonological working memory tasks when they were on stimulant medication than when they were not. Additionally, participants who were more physically active during the tasks tended to perform better on these tasks.

Study participants also performed better on visuospatial working memory tasks when they were using stimulant medication compared to when they were not. More active children also tended to perform better on these tasks. Analyses revealed that the effects of the medications on visuospatial working memory performance were greater in children who were the most physically active.

“Consistent with previous research, this study found that when children are medicated, they generally perform better on PH and VS WM [phonological and visuospatial working memory] tasks. Additionally, there was a relationship between scores on PH and VS WM tasks and the level of naturally occurring movement during the task as measured by actigraphy watches. Further, this study found that there was an optimal level of movement for each individual that is helpful for WM [working memory] tasks as seen by decreased score when there is little movement or too much movement,” the study authors concluded.

The study sheds light on the effects of stimulant medication on the working memory of children with ADHD. However, it should be noted that the study only examined the two aforementioned types of working memory and did not report the effects of medication on central executive working memory—the component that controls attention, coordinates cognitive processes, and manages the flow of information between different types of memory in the brain.

The paper, “The Impact of Stimulant Medication on the Relation Between Working Memory and Activity Level in ADHD,” was authored by Emily Wiegers, Annie Garner, Morgan Jusko, Jessica N. Smith, Mileini Campez, Andrew Greiner, Elizabeth Gnagy, William E. Pelham, and Joseph Raiker Jr.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

Microdoses of LSD enhance neural complexity, study finds
Depression

Little-known psychedelic drug shows promise in treating low motivation in depression

May 9, 2025

Researchers investigating the psychedelic drug DOPR discovered that very low doses can enhance motivation in low-performing mice—without triggering behaviors linked to hallucinations. The findings point to the therapeutic potential of psychedelics at doses too low to alter perception.

Read moreDetails
AI-driven brain training reduces impulsiveness in kids with ADHD, study finds
ADHD

AI-driven brain training reduces impulsiveness in kids with ADHD, study finds

May 9, 2025

Researchers found that a personalized, game-based cognitive therapy powered by artificial intelligence significantly reduced impulsiveness and inattentiveness in children with ADHD. Brain scans showed signs of neurological improvement, highlighting the potential of AI tools in mental health treatment.

Read moreDetails
Researchers uncover causal evidence that cannabis legalization reduces problematic consumption
Cannabis

Researchers uncover causal evidence that cannabis legalization reduces problematic consumption

May 8, 2025

Researchers in Switzerland have completed the first randomized trial comparing legal and illegal cannabis use. The study suggests that public health-oriented cannabis access may help reduce misuse, particularly among people with more complex patterns of drug use.

Read moreDetails
A dose of psilocybin stirred the brain of a barely conscious woman
Neuroimaging

A dose of psilocybin stirred the brain of a barely conscious woman

May 7, 2025

In a groundbreaking case report, scientists administered psilocybin to a woman in a minimally conscious state and observed increased brain complexity and new spontaneous behavior—offering a glimpse into how psychedelics might influence consciousness in severe brain injury patients.

Read moreDetails
Genetic risk for alcoholism linked to brain immune cell response, study finds
Addiction

Genetic risk for alcoholism linked to brain immune cell response, study finds

May 7, 2025

New research shows that microglia—the brain’s immune cells—respond more strongly to alcohol in people with a high genetic risk for alcohol use disorder. The findings offer insight into how inherited factors can shape brain responses to alcohol exposure.

Read moreDetails
Around 27% of individuals with ADHD develop cannabis use disorder at some point in their lives, study finds
Cannabis

Daily use of cannabis is strongly associated with chronic inflammation, study finds

May 6, 2025

A new study suggests daily cannabis use may be linked to chronic inflammation. Researchers found that young adults who used cannabis frequently had higher levels of suPAR, an inflammatory marker, while occasional users did not.

Read moreDetails
CBD amplifies THC’s impact instead of mitigating it, new cannabis research reveals
Addiction

N-acetylcysteine does not appear to be effective for cannabis use disorder

May 4, 2025

In a study of young people with cannabis use disorder, N-acetylcysteine failed to outperform a placebo in reducing cannabis use, suggesting that the supplement may not be effective unless combined with more intensive behavioral interventions like contingency management.

Read moreDetails
Childhood neglect is linked to troubling health outcomes, but two factors can dramatically change this trajectory, study suggests
ADHD

ADHD in formerly institutionalized children tied to slower physical and brain growth

May 4, 2025

A new study finds that children raised in institutions show slower physical and brain development, especially if diagnosed with ADHD. Early placement into foster care helped, but delays remained—highlighting the lasting effects of early adversity on growth and mental health.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Schizophrenia may accelerate brain ageing, new study finds

New study uncovers an intriguing liver–brain connection

Parental warmth—not poverty or danger—predicts positive world beliefs in adulthood

Diets high in fat and sugar appear to harm cognitive function

Little-known psychedelic drug shows promise in treating low motivation in depression

AI-driven brain training reduces impulsiveness in kids with ADHD, study finds

Neuroscientists use brain implants and AI to map language processing in real time

New study sheds light on how personality, power, and identity shape relationship satisfaction

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy